
Catherine S. Hibbert
Examiner (ID: 16599, Phone: (571)270-3053 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1658, 1636, 1609 |
| Total Applications | 988 |
| Issued Applications | 475 |
| Pending Applications | 136 |
| Abandoned Applications | 423 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20178237
[patent_doc_number] => 20250262195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => METHOD TO PREVENT AND TREAT DIABETIC RETINOPATHY BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
[patent_app_type] => utility
[patent_app_number] => 19/200045
[patent_app_country] => US
[patent_app_date] => 2025-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19200045
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/200045 | METHOD TO PREVENT AND TREAT DIABETIC RETINOPATHY BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS | May 5, 2025 | Pending |
Array
(
[id] => 20041303
[patent_doc_number] => 20250179525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR
[patent_app_type] => utility
[patent_app_number] => 19/051398
[patent_app_country] => US
[patent_app_date] => 2025-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19051398
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/051398 | METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR | Feb 11, 2025 | Pending |
Array
(
[id] => 20031286
[patent_doc_number] => 20250169508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => INSECT NEUROPEPTIDES 8
[patent_app_type] => utility
[patent_app_number] => 19/044943
[patent_app_country] => US
[patent_app_date] => 2025-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19044943
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/044943 | INSECT NEUROPEPTIDES 8 | Feb 3, 2025 | Pending |
Array
(
[id] => 19450261
[patent_doc_number] => 20240310391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => HDL-ASSOCIATED PROTEIN EXTRACTION AND DETECTION
[patent_app_type] => utility
[patent_app_number] => 18/615987
[patent_app_country] => US
[patent_app_date] => 2024-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18615987
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/615987 | HDL-ASSOCIATED PROTEIN EXTRACTION AND DETECTION | Mar 24, 2024 | Pending |
Array
(
[id] => 19232193
[patent_doc_number] => 20240189384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => Compositions Comprising Antimicrobial Peptides
[patent_app_type] => utility
[patent_app_number] => 18/587268
[patent_app_country] => US
[patent_app_date] => 2024-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18587268
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/587268 | Compositions Comprising Antimicrobial Peptides | Feb 25, 2024 | Pending |
Array
(
[id] => 19265685
[patent_doc_number] => 20240209384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => Multi-Pulse Transfection Methods And Cells
[patent_app_type] => utility
[patent_app_number] => 18/587120
[patent_app_country] => US
[patent_app_date] => 2024-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18587120
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/587120 | Multi-Pulse Transfection Methods And Cells | Feb 25, 2024 | Pending |
Array
(
[id] => 19709555
[patent_doc_number] => 20250019697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => MODIFIED U6 PROMOTER SYSTEM FOR TISSUE SPECIFIC EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/444111
[patent_app_country] => US
[patent_app_date] => 2024-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18444111
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/444111 | MODIFIED U6 PROMOTER SYSTEM FOR TISSUE SPECIFIC EXPRESSION | Feb 15, 2024 | Pending |
Array
(
[id] => 19432984
[patent_doc_number] => 20240301482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => METHODS AND COMPOSITIONS FOR DETERMINING PLOIDY
[patent_app_type] => utility
[patent_app_number] => 18/441502
[patent_app_country] => US
[patent_app_date] => 2024-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18441502
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/441502 | METHODS AND COMPOSITIONS FOR DETERMINING PLOIDY | Feb 13, 2024 | Pending |
Array
(
[id] => 19556831
[patent_doc_number] => 20240368623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => NEW METHODS AND SYSTEMS FOR TARGETED GENE MANIPULATION
[patent_app_type] => utility
[patent_app_number] => 18/412406
[patent_app_country] => US
[patent_app_date] => 2024-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18412406
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/412406 | NEW METHODS AND SYSTEMS FOR TARGETED GENE MANIPULATION | Jan 11, 2024 | Pending |
Array
(
[id] => 19113089
[patent_doc_number] => 20240124839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => GENERATION OF NEURAL STEM CELLS FROM HUMAN TROPHOBLAST STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/521884
[patent_app_country] => US
[patent_app_date] => 2023-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18521884
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/521884 | GENERATION OF NEURAL STEM CELLS FROM HUMAN TROPHOBLAST STEM CELLS | Nov 27, 2023 | Abandoned |
Array
(
[id] => 20480580
[patent_doc_number] => 12529051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-20
[patent_title] => Methods of treating amyotrophic lateral sclerosis (ALS)
[patent_app_type] => utility
[patent_app_number] => 18/505163
[patent_app_country] => US
[patent_app_date] => 2023-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 25
[patent_no_of_words] => 5425
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18505163
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/505163 | Methods of treating amyotrophic lateral sclerosis (ALS) | Nov 8, 2023 | Issued |
Array
(
[id] => 19265326
[patent_doc_number] => 20240209025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => COMPOSITIONS AND METHODS FOR MODULATING GAMMA-C-CYTOKINE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/502536
[patent_app_country] => US
[patent_app_date] => 2023-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18502536
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/502536 | COMPOSITIONS AND METHODS FOR MODULATING GAMMA-C-CYTOKINE ACTIVITY | Nov 5, 2023 | Abandoned |
Array
(
[id] => 19667526
[patent_doc_number] => 12180254
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-12-31
[patent_title] => Factor H variants for treatment of disease
[patent_app_type] => utility
[patent_app_number] => 18/494883
[patent_app_country] => US
[patent_app_date] => 2023-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 63
[patent_no_of_words] => 17641
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18494883
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/494883 | Factor H variants for treatment of disease | Oct 25, 2023 | Issued |
Array
(
[id] => 19417380
[patent_doc_number] => 20240293503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING MICROBIAL INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 18/479600
[patent_app_country] => US
[patent_app_date] => 2023-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18479600
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/479600 | METHODS AND COMPOSITIONS FOR TREATING MICROBIAL INFLAMMATION | Oct 1, 2023 | Pending |
Array
(
[id] => 18972264
[patent_doc_number] => 20240052356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells
[patent_app_type] => utility
[patent_app_number] => 18/467952
[patent_app_country] => US
[patent_app_date] => 2023-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18467952
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/467952 | Cas9/RNA complexes for inducing modifications of target endogenous nucleic acid sequences in nucleuses of eukaryotic cells | Sep 14, 2023 | Issued |
Array
(
[id] => 18972264
[patent_doc_number] => 20240052356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells
[patent_app_type] => utility
[patent_app_number] => 18/467952
[patent_app_country] => US
[patent_app_date] => 2023-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18467952
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/467952 | Cas9/RNA complexes for inducing modifications of target endogenous nucleic acid sequences in nucleuses of eukaryotic cells | Sep 14, 2023 | Issued |
Array
(
[id] => 18923363
[patent_doc_number] => 20240026367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells
[patent_app_type] => utility
[patent_app_number] => 18/467967
[patent_app_country] => US
[patent_app_date] => 2023-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18467967
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/467967 | Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells | Sep 14, 2023 | Pending |
Array
(
[id] => 18860271
[patent_doc_number] => 20230414705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => Hard Tissue Therapeutics
[patent_app_type] => utility
[patent_app_number] => 18/242406
[patent_app_country] => US
[patent_app_date] => 2023-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18242406
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/242406 | Hard Tissue Therapeutics | Sep 4, 2023 | Pending |
Array
(
[id] => 18829648
[patent_doc_number] => 20230398172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY
[patent_app_type] => utility
[patent_app_number] => 18/115847
[patent_app_country] => US
[patent_app_date] => 2023-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18115847
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/115847 | METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY | Aug 29, 2023 | Abandoned |
Array
(
[id] => 19034163
[patent_doc_number] => 20240083978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => METHODS AND COMPOSITIONS FOR EGG WHITE PROTEIN PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/455552
[patent_app_country] => US
[patent_app_date] => 2023-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455552
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/455552 | METHODS AND COMPOSITIONS FOR EGG WHITE PROTEIN PRODUCTION | Aug 23, 2023 | Pending |